OXA β-lactamases in Acinetobacter: The story so far

177Citations
Citations of this article
179Readers
Mendeley users who have this article in their library.

Abstract

The emergence of carbapenem resistance in Acinetobacter baumannii has become a global concern since these β-lactams are often the only effective treatment left against many multiresistant strains. A recent development has been the discovery of a novel group of narrow-spectrum OXA β-lactamases in carbapenem-resistant strains, some of which have acquired the ability to hydrolyse the carbapenems. The first of these was found in a strain isolated in Edinburgh before imipenem was in use in the hospital. Whether these carbapenemases have been acquired or are part of the genetic make-up of this species has yet to be determined. More importantly, however, they represent an important stage in the evolution of antibiotic resistance in Acinetobacter. This paper discusses the emergence of these unusual enzymes over the past decade. © The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.

Cite

CITATION STYLE

APA

Brown, S., & Amyes, S. (2006, January). OXA β-lactamases in Acinetobacter: The story so far. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dki425

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free